Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 86, 3-9
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (NHMRC)
- Cancer Council of Victoria
- Victorian Government of Australia
This publication has 76 references indexed in Scilit:
- Epithelial NAIPs protect against colonic tumorigenesisJournal of Experimental Medicine, 2015
- The Inflammasomes and Autoinflammatory SyndromesAnnual Review of Pathology: Mechanisms of Disease, 2015
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growthNature Medicine, 2012
- NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223The Journal of Immunology, 2012
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasomeGut, 2010
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancerJournal of Experimental Medicine, 2010
- Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 ExpressionThe Journal of Immunology, 2009
- Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive ImmunityImmunity, 2009
- Initial description of the human NLRP3 promoterGenes & Immunity, 2008
- NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory DisorderImmunity, 2004